Fulvestrant nano conjugate (Shanghai bestlink Biotechnology )

N/A

Report date: 2026/01/27 10:54:37
NME

Base Information

Drug NameFulvestrant nano conjugate (Shanghai bestlink Biotechnology )
Drug Alias NameBL0175BL-0175
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors antagonistsEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursMenopausal symptoms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai bestlink Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai bestlink Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursMenopausal symptoms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A